Skip to main content
Erschienen in: Rheumatology International 1/2011

01.01.2011 | Original Article

Serum melatonin levels in ankylosing spondilitis: correlation with disease activity

Erschienen in: Rheumatology International | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

This study was carried out to determine the serum levels of melatonin (MLT) in patients with ankylosing spondilitis (AS) and to evaluate its correlation with disease activity. We assessed clinical characteristics and labaratory parameters. Serum samples from 36 patients (25 males, 11 females) with active AS and 25 healthy subjects (18 males, 7 females) were collected. MLT levels were measured by enzyme-linked immunosorbent assay, and disease activity of AS was assessed according to the Bath AS disease activity index (BASDAI), the erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). Then, the results were compared with those from 25 healty controls. The serum levels of MLT were significantly increased in AS patients as compared to healthy controls (p < 0.05). MLT levels were correlated with BASDAI (r = 0.871, p < 0.001) and CRP levels (r = 0.691, p < 0.001), but not with ESR, in patients with AS. Our results suggest a possible role for this immunoregulatory hormone in the disease activity in AS patients.
Literatur
1.
Zurück zum Zitat Maksymowych WP (2003) Spondyloartropathies: etiology and pathogenesis of ankylosing spondylitis. In: Hochberg M, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology, 3rd edn. Elsevier, Philadelphia, pp 1183–1192 Maksymowych WP (2003) Spondyloartropathies: etiology and pathogenesis of ankylosing spondylitis. In: Hochberg M, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology, 3rd edn. Elsevier, Philadelphia, pp 1183–1192
2.
Zurück zum Zitat Reiter RJ, Melchiorri D, Seweryrek E, Poeggeler B, Barlow-Walden L, Chuang J et al (1995) A review of the evidence supporting melatonin’s role as an antioxidant. J Pineal Res 18:1–11CrossRefPubMed Reiter RJ, Melchiorri D, Seweryrek E, Poeggeler B, Barlow-Walden L, Chuang J et al (1995) A review of the evidence supporting melatonin’s role as an antioxidant. J Pineal Res 18:1–11CrossRefPubMed
3.
Zurück zum Zitat Reiter RJ, Calvo JR, Karbownik M, Qi WB, Tan DX (2000) Melatonin and its relation to the immune system and inflammation. Ann N Y Acad Sci 917:376–386CrossRefPubMed Reiter RJ, Calvo JR, Karbownik M, Qi WB, Tan DX (2000) Melatonin and its relation to the immune system and inflammation. Ann N Y Acad Sci 917:376–386CrossRefPubMed
4.
Zurück zum Zitat Reiter RJ (2003) Melatonin: clinical relevance. Best Pract Res Clin Endocrinol Metab 17:273–285CrossRefPubMed Reiter RJ (2003) Melatonin: clinical relevance. Best Pract Res Clin Endocrinol Metab 17:273–285CrossRefPubMed
5.
Zurück zum Zitat Pandi-Perumal SR, Srinivasan V, Maestroni GJM, Cardinali DP, Poegaler B, Hardeland R (2006) Melatonin. Nature ‘s most versatile biological singnal? FEBS J 273:2813–2838CrossRefPubMed Pandi-Perumal SR, Srinivasan V, Maestroni GJM, Cardinali DP, Poegaler B, Hardeland R (2006) Melatonin. Nature ‘s most versatile biological singnal? FEBS J 273:2813–2838CrossRefPubMed
6.
Zurück zum Zitat Maharaj DS, Glass BD, Daya S (2007) Melatonin: new places in therapy. Biosci Rep 27:299–320CrossRefPubMed Maharaj DS, Glass BD, Daya S (2007) Melatonin: new places in therapy. Biosci Rep 27:299–320CrossRefPubMed
7.
Zurück zum Zitat Altun A, Ugur-Altun B (2007) Melatonin.Therapeutic and clinical utilization. Int J Clin Pract 61:835–845CrossRefPubMed Altun A, Ugur-Altun B (2007) Melatonin.Therapeutic and clinical utilization. Int J Clin Pract 61:835–845CrossRefPubMed
8.
Zurück zum Zitat Szczepanik M (2007) Melatonin and its influence on immune system. J Physiol Pharmacol 58(Suppl 6):115–124PubMed Szczepanik M (2007) Melatonin and its influence on immune system. J Physiol Pharmacol 58(Suppl 6):115–124PubMed
9.
Zurück zum Zitat Forrest CM, Mackay GM, Stoy N, Stone TW, Darlington LG (2007) Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin. Br J Clin Pharmacol 64:517–526CrossRefPubMed Forrest CM, Mackay GM, Stoy N, Stone TW, Darlington LG (2007) Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin. Br J Clin Pharmacol 64:517–526CrossRefPubMed
10.
Zurück zum Zitat Cutolo M, Otsa K, Aakr O, Sulli A (2005) Nocturnal hormones and clinical rhythms in rheumatoid arthritis. Ann N Y Acad Sci 1051:372–381CrossRefPubMed Cutolo M, Otsa K, Aakr O, Sulli A (2005) Nocturnal hormones and clinical rhythms in rheumatoid arthritis. Ann N Y Acad Sci 1051:372–381CrossRefPubMed
11.
Zurück zum Zitat Cutolo M, Maestroni GJ, Otsa K, Aakre O, Villaggio B, Capellino S et al (2005) Cirdacidian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. Ann Rheum Dis 64:212–216CrossRefPubMed Cutolo M, Maestroni GJ, Otsa K, Aakre O, Villaggio B, Capellino S et al (2005) Cirdacidian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. Ann Rheum Dis 64:212–216CrossRefPubMed
12.
Zurück zum Zitat West SK, Oosthuizen JM (1992) Melatonin Levels are decreased in rheumatoid arthritis. J Basic Clin Physiol Pharmacol 3:33–40PubMed West SK, Oosthuizen JM (1992) Melatonin Levels are decreased in rheumatoid arthritis. J Basic Clin Physiol Pharmacol 3:33–40PubMed
13.
Zurück zum Zitat Reiter RJ, Tan DX, Manchester CC, Pilar Terron M, Flores LJ, Koppisepi S (2007) Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv Med Sci 52:11–28PubMed Reiter RJ, Tan DX, Manchester CC, Pilar Terron M, Flores LJ, Koppisepi S (2007) Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv Med Sci 52:11–28PubMed
14.
Zurück zum Zitat Cutolo M, Seriolo B, Craviotta C, Pizzorni C, Sulli A (2003) Circadian rhytms in RA. Ann Rheum Dis 62:593–596CrossRefPubMed Cutolo M, Seriolo B, Craviotta C, Pizzorni C, Sulli A (2003) Circadian rhytms in RA. Ann Rheum Dis 62:593–596CrossRefPubMed
15.
Zurück zum Zitat Cutolo M, Villaggio B, Otsa K, Aakre O, Sulli A, Seriolo B (2005) Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease symptoms. Autoimmun Rev 4:497–502CrossRefPubMed Cutolo M, Villaggio B, Otsa K, Aakre O, Sulli A, Seriolo B (2005) Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease symptoms. Autoimmun Rev 4:497–502CrossRefPubMed
16.
Zurück zum Zitat Cutolo M, Maestroni GJM (2005) The melatonin–cytokine connection in rheumatoid arthritis. Ann Rheum Dis 64:1109–1111CrossRefPubMed Cutolo M, Maestroni GJM (2005) The melatonin–cytokine connection in rheumatoid arthritis. Ann Rheum Dis 64:1109–1111CrossRefPubMed
17.
Zurück zum Zitat Maestroni GJ, Cardinali DP, Esquifino AI, Pandi-Perumal SR (2005) Does melatonin play a disease-promoting role in rheumatoid arthritis? J Neuroimmunol 158:106–111CrossRefPubMed Maestroni GJ, Cardinali DP, Esquifino AI, Pandi-Perumal SR (2005) Does melatonin play a disease-promoting role in rheumatoid arthritis? J Neuroimmunol 158:106–111CrossRefPubMed
18.
Zurück zum Zitat Sulli A, Maestroni GJ, Villaggio B, Hertens E, Craviotto C, Pizzorni C et al (2002) Melatonin serum levels in rheumatoid arthritis. Ann N Y Acad Sci 966:276–278CrossRefPubMed Sulli A, Maestroni GJ, Villaggio B, Hertens E, Craviotto C, Pizzorni C et al (2002) Melatonin serum levels in rheumatoid arthritis. Ann N Y Acad Sci 966:276–278CrossRefPubMed
19.
Zurück zum Zitat Maestroni GJ, Sulli A, Pizzorni C, Villaggio B, Cutolo M (2002) Melatonin in rheumatoid arthritis: synovial macrophages show melatonin receptors. Ann N Y Acad Sci 966:271–275CrossRefPubMed Maestroni GJ, Sulli A, Pizzorni C, Villaggio B, Cutolo M (2002) Melatonin in rheumatoid arthritis: synovial macrophages show melatonin receptors. Ann N Y Acad Sci 966:271–275CrossRefPubMed
20.
Zurück zum Zitat Wollmann HA, Pleyer U, Friedel S (1994) Neuro endocrine alterations in uveits patients. Graefes Arch Clin Exp Ophthalmol 232:297–301CrossRefPubMed Wollmann HA, Pleyer U, Friedel S (1994) Neuro endocrine alterations in uveits patients. Graefes Arch Clin Exp Ophthalmol 232:297–301CrossRefPubMed
21.
Zurück zum Zitat Ha E, Choe BK, Jung KH, Yoon SH, Park HJ, Park HK (2005) Positive relationship between melatonin receptor type 1 B polymorphism and rheumatoid factor in rheumatoid arthritis patients in the Korean population. J Pineal Res 39:201–205CrossRefPubMed Ha E, Choe BK, Jung KH, Yoon SH, Park HJ, Park HK (2005) Positive relationship between melatonin receptor type 1 B polymorphism and rheumatoid factor in rheumatoid arthritis patients in the Korean population. J Pineal Res 39:201–205CrossRefPubMed
Metadaten
Titel
Serum melatonin levels in ankylosing spondilitis: correlation with disease activity
Publikationsdatum
01.01.2011
Erschienen in
Rheumatology International / Ausgabe 1/2011
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1223-x

Weitere Artikel der Ausgabe 1/2011

Rheumatology International 1/2011 Zur Ausgabe

Acknowledgement to Referees

Referees 2010

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.